We assessed the risk of pneumonia due to Pneumocystis carinii in 1665 participants in the Multicenter AIDS Cohort Study who were seropositive for human immunodeficiency virus type 1 (HIV-1) but did not have the acquired immunodeficiency syndrome (AIDS) and were not receiving prophylaxis against P. carinii. During 48 months of follow-up, 168 participants (10.1 percent) had a first episode of P. carinii pneumonia. The risk was greatly increased in participants with CD4+ cell counts at base line of 200 per cubic millimeter or less (relative risk, 4.9; 95 percent confidence interval, 3.1 to 8.0). Although most participants (60.7 percent) described no HIV-1-related symptoms at the clinic visit at which a CD4+ cell count of 200 per cubic millimeter or less was first noted, this finding during follow-up was also associated with an increased risk of P. carinii pneumonia. The development of thrush or fever significantly and independently increased the risk of P. carinii pneumonia in these patients (adjusted relative risks, 1.86 and 2.15 for thrush and fever, respectively). Most participants with CD4+ cell counts above 200 per cubic millimeter who had P. carinii pneumonia within six months were symptomatic. We conclude that P. carinii pneumonia is unlikely to develop in HIV-1-infected patients unless their CD4+ cells are depleted to 200 per cubic millimeter or below or the patients are symptomatic, and therefore that prophylaxis should be reserved for such patients.
Source Information
Comprehensive AIDS Center, Northwestern University Medical School, Chicago, IL 60611.
This article has been cited by other articles:
Antinori, S., Nebuloni, M., Magni, C., Fasan, M., Adorni, F., Viola, A., Corbellino, M., Galli, M., Vago, G., Parravicini, C., Ridolfo, A. L.
(2009). Trends in the Postmortem Diagnosis of Opportunistic Invasive Fungal Infections in Patients With AIDS: A Retrospective Study of 1,630 Autopsies Performed Between 1984 and 2002. Am J Clin Pathol
132: 221-227
[Abstract][Full Text]
Kovacs, J. A., Masur, H.
(2009). Evolving Health Effects of Pneumocystis: One Hundred Years of Progress in Diagnosis and Treatment. JAMA
301: 2578-2585
[Abstract][Full Text]
Liao, C.-P., Lasbury, M. E., Wang, S.-H., Zhang, C., Durant, P. J., Murakami, Y., Matsufuji, S., Lee, C.-H.
(2009). Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages. J. Biol. Chem.
284: 8174-8184
[Abstract][Full Text]
Hull, M. W., Phillips, P., Montaner, J. S. G.
(2008). Changing Global Epidemiology of Pulmonary Manifestations of HIV/AIDS. Chest
134: 1287-1298
[Abstract][Full Text]
Rudner, X. L., Happel, K. I., Young, E. A., Shellito, J. E.
(2007). Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection. Infect. Immun.
75: 3055-3061
[Abstract][Full Text]
Huang, L., Morris, A., Limper, A. H., Beck, J. M., on behalf of the ATS Pneumocystis Workshop Partici,
(2006). An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP). Proc Am Thorac Soc
3: 655-664
[Abstract][Full Text]
McKinley, L., Logar, A. J., McAllister, F., Zheng, M., Steele, C., Kolls, J. K.
(2006). Regulatory T Cells Dampen Pulmonary Inflammation and Lung Injury in an Animal Model of Pneumocystis Pneumonia. J. Immunol.
177: 6215-6226
[Abstract][Full Text]
Lee, S. A.
(2006). A Review of Pneumocystis Pneumonia. Journal of Pharmacy Practice
19: 5-9
[Abstract]
Hui, M., Kwok, W. T.
(2006). Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study. J Med Microbiol
55: 85-88
[Abstract][Full Text]
Rosen, M. J.
(2006). Cough in the Immunocompromised Host: ACCP Evidence-Based Clinical Practice Guidelines. Chest
129: 204S-205S
[Abstract][Full Text]
Hammer, S. M.
(2005). Clinical practice. Management of newly diagnosed HIV infection.. NEJM
353: 1702-1710
[Full Text]
Zhang, J., Tachado, S. D., Patel, N., Zhu, J., Imrich, A., Manfruelli, P., Cushion, M., Kinane, T. B., Koziel, H.
(2005). Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J. Leukoc. Biol.
78: 665-674
[Abstract][Full Text]
Nachman, S., Gona, P., Dankner, W., Weinberg, A., Yogev, R., Gershon, A., Rathore, M., Read, J. S., Huang, S., Elgie, C., Hudgens, K., Hughes, W.
(2005). The Rate of Serious Bacterial Infections Among HIV-Infected Children With Immune Reconstitution Who Have Discontinued Opportunistic Infection Prophylaxis. Pediatrics
115: e488-e494
[Abstract][Full Text]
Rodriguez, M., Fishman, J. A.
(2004). Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients. Clin. Microbiol. Rev.
17: 770-782
[Abstract][Full Text]
Thomas, C. F. Jr., Limper, A. H.
(2004). Pneumocystis Pneumonia. NEJM
350: 2487-2498
[Full Text]
Vestereng, V. H., Kovacs, J. A.
(2004). Inability of Pneumocystis organisms to incorporate bromodeoxyuridine suggests the absence of a salvage pathway for thymidine. Microbiology
150: 1179-1182
[Abstract][Full Text]
Thullen, T. D., Ashbaugh, A. D., Daly, K. R., Linke, M. J., Steele, P. E., Walzer, P. D.
(2003). New Rat Model of Pneumocystis Pneumonia Induced by Anti-CD4+ T-Lymphocyte Antibodies. Infect. Immun.
71: 6292-6297
[Abstract][Full Text]
Lebron, F., Vassallo, R., Puri, V., Limper, A. H.
(2003). Pneumocystis carinii Cell Wall {beta}-Glucans Initiate Macrophage Inflammatory Responses through NF-{kappa}B Activation. J. Biol. Chem.
278: 25001-25008
[Abstract][Full Text]
Lubis, N, Baylis, D, Short, A, Stebbing, J, Teague, A, Portsmouth, S, Bower, M, Nelson, M, Gazzard, B
(2003). Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia. Postgrad. Med. J.
79: 164-166
[Abstract][Full Text]
Masur, P. b. H., Kaplan, J. E., Holmes, K. K.
(2002). Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons--2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. ANN INTERN MED
137: 435-478
[Abstract][Full Text]
Baggish, A. L., Hill, D. R.
(2002). Antiparasitic Agent Atovaquone. Antimicrob. Agents Chemother.
46: 1163-1173
[Full Text]
Kovacs, J. A., Gill, V. J., Meshnick, S., Masur, H.
(2001). New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA
286: 2450-2460
[Abstract][Full Text]
Newman, S. L., Holly, A.
(2001). Candida albicans Is Phagocytosed, Killed, and Processed for Antigen Presentation by Human Dendritic Cells. Infect. Immun.
69: 6813-6822
[Abstract][Full Text]
Vassallo, R., Kottom, T. J., Standing, J. E., Limper, A. H.
(2001). Vitronectin and Fibronectin Function as Glucan Binding Proteins Augmenting Macrophage Responses to Pneumocystis carinii. Am. J. Respir. Cell Mol. Bio.
25: 203-211
[Abstract][Full Text]
Bender, M. A., Sax, P. E., Le Moal, G., Breux, J.-P., Roblot, F., Lopez Bernaldo de Quiros, J. C., Miro, J. M., Pena, J. M., Lundgren, J., Reiss, P., Ledergerber, B.
(2001). Discontinuing Prophylaxis against Pneumocystis carinii Pneumonia. NEJM
344: 1639-1641
[Full Text]
Wei, C. C-Y, Gardner, S., Rachlis, A., Pack, L. L., Chan, C. K. N.
(2001). Risk Factors for Prophylaxis Failure in Patients Receiving Aerosol Pentamidine for Pneumocystis carinii Pneumonia Prophylaxis. Chest
119: 1427-1433
[Abstract][Full Text]
de Quiros, J. C. L. B., Miro, J. M., Pena, J. M., Podzamczer, D., Alberdi, J. C., Martinez, E., Cosin, J., Claramonte, X., Gonzalez, J., Domingo, P., Casado, J. L., Ribera, E., The Grupo de Estudio del SIDA 04/98,
(2001). A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against Pneumocystis carinii Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection. NEJM
344: 159-167
[Abstract][Full Text]
Ledergerber, B., Mocroft, A., Reiss, P., Furrer, H., Kirk, O., Bickel, M., Uberti-Foppa, C., Pradier, C., d'Arminio Monforte, A., Schneider, M. M.E., Lundgren, J. D.
(2001). Discontinuation of Secondary Prophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy. NEJM
344: 168-174
[Abstract][Full Text]
Purdy, B. D.
(2000). Management and Prevention of Opportunistic Infections in the HIV-Infected Patient. Journal of Pharmacy Practice
13: 475-498
[Abstract]
Martin, W. J. II, Pasula, R.
(2000). Role of Alveolar Macrophages in Host Defense against Pneumocystis carinii. Am. J. Respir. Cell Mol. Bio.
23: 434-435
[Full Text]
Mansharamani, N. G., Balachandran, D., Vernovsky, I., Garland, R., Koziel, H.
(2000). Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection. Chest
118: 712-720
[Abstract][Full Text]
Kovacs, J. A., Masur, H.
(2000). Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection. NEJM
342: 1416-1429
[Full Text]
Pelletier, R., Peter, J., Antin, C., Gonzalez, C., Wood, L., Walsh, T. J.
(2000). Emergence of Resistance of Candida albicans to Clotrimazole in Human Immunodeficiency Virus-Infected Children: In Vitro and Clinical Correlations. J. Clin. Microbiol.
38: 1563-1568
[Abstract][Full Text]
Furrer, H., Egger, M., Opravil, M., Bernasconi, E., Hirschel, B., Battegay, M., Telenti, A., Vernazza, P. L., Rickenbach, M., Flepp, M., Malinverni, R., The Swiss HIV Cohort Study,
(1999). Discontinuation of Primary Prophylaxis against Pneumocystis carinii Pneumonia in HIV-1-Infected Adults Treated with Combination Antiretroviral Therapy. NEJM
340: 1301-1306
[Abstract][Full Text]
Masur, H., Kaplan, J.
(1999). Does Pneumocystis carinii Prophylaxis Still Need to Be Lifelong?. NEJM
340: 1356-1358
[Full Text]
Walzer, P. D.
(1999). Immunological Features of Pneumocystis carinii Infection in Humans. CVI
6: 149-155
[Full Text]
Fahey, J. L.
(1998). Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection. CVI
5: 597-603
[Full Text]
Powderly, W. G., Landay, A., Lederman, M. M.
(1998). Recovery of the Immune System With Antiretroviral Therapy: The End of Opportunism?. JAMA
280: 72-77
[Abstract][Full Text]
Paltiel, A. D., Freedberg, K. A.
(1998). The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients. Interfaces
28: 34-51
[Abstract]
Paltiel, A. D., Scharfstein, J. A., Seage, G. R., Losina, E., Goldie, S. J., Weinstein, M. C., Craven, D. E., Freedberg, K. A.
(1998). A Monte Carlo Simulation of Advanced HIV Disease: Application to Prevention of CMV Infection. Med Decis Making
18: S93-S105
[Abstract]
Freedberg, K. A., Scharfstein, J. A., Seage III, G. R., Losina, E., Weinstein, M. C., Craven, D. E., Paltiel, A. D.
(1998). The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections. JAMA
279: 130-136
[Abstract][Full Text]
Hanano, R., Reifenberg, K., Kaufmann, S. H. E.
(1998). Activated Pulmonary Macrophages Are Insufficient for Resistance against Pneumocystis carinii. Infect. Immun.
66: 305-314
[Abstract][Full Text]
Boswell, S. L., van Gorder, M.
(1997). Case 27-1997- A 38-Year-Old Man with the Acquired Immunodeficiency Syndrome and Cavitary Pulmonary Lesions. NEJM
337: 619-627
[Full Text]
Kovacs, J. A., Vogel, S., Albert, J. M., Falloon, J., Davey, R. T., Walker, R. E., Polis, M. A., Spooner, K., Metcalf, J. A., Baseler, M., Fyfe, G., Lane, H. C., Dewar, R. J., Masur, H.
(1996). Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus. NEJM
335: 1350-1356
[Abstract][Full Text]
Cruz, G. D., Lamster, I. B., Begg, M. D., Phelan, J. A., Gorman, J. M., El-Sadr, W.
(1996). The Accurate Diagnosis of Oral Lesions in Human Immunodeficiency Virus Infection: Impact on Medical Staging. Arch Otolaryngol Head Neck Surg
122: 68-73
[Abstract]
Arend, S. M., Kroon, F. P., van't Wout, J. W.
(1995). Pneumocystis carinii Pneumonia in Patients Without AIDS, 1980 Through 1993: An Analysis of 78 Cases. Arch Intern Med
155: 2436-2441
[Abstract]
Czachor, J. S., Gleckman, R. A.
(1995). Selective Causes of Fever in Adult Human Immunodeficiency Virus--Infected Patients Relative to CD4+ Cell Counts. Arch Fam Med
4: 879-884
[Abstract]
Hanson, D. L., Chu, S. Y., Farizo, K. M., Ward, J. W., Adult and Adolescent Spectrum of HIV Disease Proje,
(1995). Distribution of CD4+ T Lymphocytes at Diagnosis of Acquired Immunodeficiency Syndrome--Defining and Other Human Immunodeficiency Virus--Related Illnesses. Arch Intern Med
155: 1537-1542
[Abstract]
Saah, A. J., Hoover, D. R., Peng, Y., Phair, J. P., Visscher, B., Kingsley, L. A., Schrager, L. K., the Multicenter AIDS Cohort Study, , Saah, A. J., Taylor, E., Margolick, J. B., Markham, R., McArthur, J., Farzadegan, H., Armenian, H., Graham, N., Phair, J. P., Chmiel, J. S., Cohen, B., Wolinsky, S., Detels, R., Visscher, B. R., Fahey, J. L., Giorgi, J. V., Dudley, J., Lee, M., Nishanian, P., Rinaldo, C. R. Jr, Ho, M., Kingsley, L. A., Gupta, P., Winkelstein, A., Mufloz, A., Peng, Y., Galai, N., Hoover, D. R., Nelson, K., Lisa, P. J., Su, S., Schrager, L., Kaslow, R. A., VanRaden, M. J., Seminara, D.
(1995). Predictors for Failure of Pneumocystis carinii Pneumonia Prophylaxis. JAMA
273: 1197-1202
[Abstract]
Franklin, C., Friedman, Y., Wong, T., Hu, T.-C.
(1995). Improving Long-term Prognosis for Survivors of Mechanical Ventilation in Patients With AIDS With PCP and Acute Respiratory Failure: Five-Year Follow-up of Intensive Care Unit Discharges. Arch Intern Med
155: 91-95
[Abstract]
Advisory Group on HIV Early Intervention, Second E,
(1994). Human Immunodeficiency Virus Early Intervention Physician Guidelines, Second Edition. Arch Fam Med
3: 988-1002
[Abstract]
Turner, B. J., Hecht, F. M., Ismail, R. B.
(1994). CD4+ T-Lymphocyte Measures in the Treatment of Individuals Infected With Human Immunodeficiency Virus Type 1: A Review for Clinical Practitioners. Arch Intern Med
154: 1561-1573
[Abstract]
Margolick, J. B., Munoz, A., Vlahov, D., Astemborski, J., Solomon, L., He, X.-Y., Nelson, K. E., Saah, A. J.
(1994). Direct Comparison of the Relationship Between Clinical Outcome and Change in CD4+ Lymphocytes in Human Immunodeficiency Virus--Positive Homosexual Men and Injecting Drug Users. Arch Intern Med
154: 869-875
[Abstract]
Moore, R. D., Stanton, D., Gopalan, R., Chaisson, R. E.
(1994). Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community. NEJM
330: 763-768
[Abstract][Full Text]
Dunn, D, Newell, M L, Ades, T, Peckham, C, Maria, A D
(1994). CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. BMJ
308: 437-40
[Abstract][Full Text]
(1994). Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV. DTB
32: 12-15
[Abstract][Full Text]
Basgoz, N., Mattia, A. R.
(1994). Case 4-1994- A 38-Year-Old Man with AIDS and the Recent Onset of Diarrhea, Hematochezia, Fever, and Pulmonary Infiltrates. NEJM
330: 273-280
[Full Text]
Rabeneck, L., Wray, N. P.
(1993). Predicting the Outcomes of Human Immunodeficiency Virus Infection: How Well Are We Doing?. Arch Intern Med
153: 2749-2755
[Abstract]
Girard, P.-M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Boue, F., Bouvet, E., Lecompte, T., Jean-Coulaud, P., The PRIO Study Group,
(1993). Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection. NEJM
328: 1514-1520
[Abstract][Full Text]
Weinberger, S. E.
(1993). Recent Advances in Pulmonary Medicine- Second of Two Parts. NEJM
328: 1462-1470
[Full Text]
McCarthy, B. D., Wong, J. B., Munoz, A., Sonnenberg, F. A.
(1993). Who Should Be Screened for HIV Infection? A Cost-effectiveness Analysis. Arch Intern Med
153: 1107-1116
[Abstract]
Jewett, J. F., Hecht, F. M.
(1993). Preventive Health Care for Adults With HIV Infection. JAMA
269: 1144-1153
[Abstract]
Duncan, R. A., von Reyn, C. F., Alliegro, G. M., Toossi, Z., Sugar, A. M., Levitz, S. M.
(1993). Idiopathic CD4+ T-Lymphocytopenia -- Four Patients with Opportunistic Infections and No Evidence of HIV Infection. NEJM
328: 393-398
[Abstract][Full Text]
Blatt, S. P., Lucey, C. R., Butzin, C. A., Hendrix, C. W., Lucey, D. R.
(1993). Total Lymphocyte Count as a Predictor of Absolute CD4+ Count and CD4+ Percentage in HIV-lnfected Persons. JAMA
269: 622-626
[Abstract]
Katz, M. H., Mastrucci, M. T., Leggott, P. J., Westenhouse, J., Greenspan, J. S., Scott, G. B.
(1993). Prognostic Significance of Oral Lesions in Children With Perinatally Acquired Human Immunodeficiency Virus Infection. Arch Pediatr Adolesc Med
147: 45-48
[Abstract]
Kennedy, C. A., Goetz, M. B.
(1992). Atypical Roentgenographic Manifestations of Pneumocystis carinii Pneumonia. Arch Intern Med
152: 1390-1398
[Abstract]
DiNubile, M. J., Baxter, J. D., Mirsen, T. R.
(1992). Acute Syphilitic Meningitis in a Man With Seropositivity for Human Immunodeficiency Virus Infection and Normal Numbers of CD4 T Lymphocytes. Arch Intern Med
152: 1326-1327
[Abstract]
(1992). Recommendations for Prophylaxis Against Pneumocystis carinii Pneumonia for Adults and Adolescents Infected With HIV. JAMA
267: 2294-2299
Margolick, J. B., Munoz, A., Vlahov, D., Solomon, L., Astemborski, J., Cohn, S., Nelson, K. E.
(1992). Changes in T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection. JAMA
267: 1631-1636
[Abstract]
Martin, M. A., Cox, P. H., Beck, K., Styer, C. M., Beall, G. N.
(1992). A Comparison of the Effectiveness of Three Regimens in the Prevention of Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus-Infected Patients. Arch Intern Med
152: 523-528
[Abstract]
Minkoff, H. L., DeHovitz, J. A.
(1991). Care of Women Infected With the Human Immunodeficiency Virus. JAMA
266: 2253-2258
[Abstract]
Rutstein, R. M.
(1991). Predicting Risk of Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus--Infected Children. Arch Pediatr Adolesc Med
145: 922-924
[Abstract]
Yarchoan, R., Venzon, D. J., Pluda, J. M., Lietzau, J., Wyvill, K. M., Tsiatis, A. A., Steinberg, S. M., Broder, S.
(1991). CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy. ANN INTERN MED
115: 184-189
[Abstract]
Kovacs, A., Frederick, T., Church, J., Eller, A., Oxtoby, M., Mascola, L.
(1991). CD4 T-Lymphocyte Counts and Pneumocystis carinii Pneumonia in Pediatric HIV Infection. JAMA
265: 1698-1703
[Abstract]
(1990). Questions and Answers. JAMA
263: 2510-2514
Previous
